Related Experiment Video
Updated: May 25, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Metabolism of benzo(e)pyrene by rat liver microsomal enzymes
M C MacLeod1, W Levin, A H Conney
1Biology Division, Oak Ridge National Laboratory, Oak Ridge, TN 37830, USA.
Abstract:
Metabolites of benzo(e)pyrene (B[e]P) formed upon incubation of [3H]-B[e]P with hepatic microsomes from control and induced rats have been separated by high-pressure liquid chromatography and identified by comparison of retention times, absorbance and fluorescence spectra with those of synthetic standards. The major metabolite produced was B[e]P-4,5-dihydrodiol, accounting for 20-30% of the total metabolism depending on the source of the microsomes. This was followed by a phenolic metabolite (shown not to be 4-OH-; 9-OH-; or 10-OH-B[e]P). A possible proximate carcinogenic derivative of B[e]P, B[e]P-9,10-dihydrodiol, was identified, but was found to constitute less than 1% of the total metabolites. Similar results were obtained with a purified and reconstituted mixed-function oxidase system. In these later incubations, production of the dihydrodiols was dependent on the addition of purified epoxide hydrase to the incubation mixtures. These results suggest that formation of the reactive diol-epoxide, 9,10-dihydroxy-11,12-epoxy-9,10,11,-12-tetrahydro-B[e]P, a potential ultimate carcinogenic metabolite of B[e]P, is not favored by rat liver enzymes. This provides a partial explanation for the lack of carcinogenicity of B[e]P within the framework of the bay region theory of chemical carcinogenesis.
Related Concept Videos
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Bioactivation and Tissue Toxicity
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Metabolism: Phase I Reactions
Phase I Oxidative Reactions: Overview

